annual CFI:
-$553.37M-$374.28M(-208.99%)Summary
- As of today (May 29, 2025), VKTX annual cash flow from investing activities is -$553.37 million, with the most recent change of -$374.28 million (-208.99%) on December 31, 2024.
- During the last 3 years, VKTX annual CFI has fallen by -$591.33 million (-1557.76%).
- VKTX annual CFI is now -1110.66% below its all-time high of $54.75 million, reached on December 31, 2022.
Performance
VKTX Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$63.24M+$56.66M(+860.59%)Summary
- As of today (May 29, 2025), VKTX quarterly cash flow from investing activities is $63.24 million, with the most recent change of +$56.66 million (+860.59%) on March 31, 2025.
- Over the past year, VKTX quarterly CFI has increased by +$523.04 million (+113.76%).
- VKTX quarterly CFI is now at all-time high.
Performance
VKTX quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
-$30.33M+$523.04M(+94.52%)Summary
- As of today (May 29, 2025), VKTX TTM cash flow from investing activities is -$30.33 million, with the most recent change of +$523.04 million (+94.52%) on March 31, 2025.
- Over the past year, VKTX TTM CFI has increased by +$610.75 million (+95.27%).
- VKTX TTM CFI is now -140.49% below its all-time high of $74.90 million, reached on September 30, 2022.
Performance
VKTX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VKTX Cash from investing Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -209.0% | +113.8% | +95.3% |
3 y3 years | -1557.8% | +3806.4% | -165.6% |
5 y5 years | -7514.8% | +467.1% | -215.7% |
VKTX Cash from investing Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -1110.7% | at low | at high | +113.8% | -140.5% | +95.3% |
5 y | 5-year | -1110.7% | at low | at high | +113.8% | -140.5% | +95.3% |
alltime | all time | -1110.7% | at low | at high | +113.8% | -140.5% | +95.3% |
VKTX Cash from investing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $63.24M(+860.6%) | -$30.33M(-94.5%) |
Dec 2024 | -$553.37M(+209.0%) | $6.58M(-74.6%) | -$553.37M(+5.6%) |
Sep 2024 | - | $25.90M(-120.5%) | -$524.22M(-6.8%) |
Jun 2024 | - | -$126.06M(-72.6%) | -$562.65M(-12.2%) |
Mar 2024 | - | -$459.79M(-1386.7%) | -$641.08M(+258.0%) |
Dec 2023 | -$179.09M(-427.1%) | $35.73M(-385.1%) | -$179.09M(-13.7%) |
Sep 2023 | - | -$12.53M(-93.9%) | -$207.56M(+23.5%) |
Jun 2023 | - | -$204.48M(-9403.1%) | -$168.13M(-403.9%) |
Mar 2023 | - | $2.20M(-69.7%) | $55.33M(+1.1%) |
Dec 2022 | $54.75M(+44.2%) | $7.26M(-73.0%) | $54.75M(-26.9%) |
Sep 2022 | - | $26.89M(+41.7%) | $74.90M(+21.5%) |
Jun 2022 | - | $18.98M(+1072.3%) | $61.63M(+33.4%) |
Mar 2022 | - | $1.62M(-94.1%) | $46.21M(+21.7%) |
Dec 2021 | $37.96M(-8.7%) | $27.41M(+101.3%) | $37.96M(-7.0%) |
Sep 2021 | - | $13.62M(+282.5%) | $40.82M(+132.3%) |
Jun 2021 | - | $3.56M(-153.7%) | $17.57M(-26.1%) |
Mar 2021 | - | -$6.63M(-121.9%) | $23.79M(-42.8%) |
Dec 2020 | $41.57M(+457.0%) | $30.27M(-414.2%) | $41.57M(>+9900.0%) |
Sep 2020 | - | -$9.63M(-198.5%) | $237.00K(-99.1%) |
Jun 2020 | - | $9.78M(-12.3%) | $25.02M(-4.6%) |
Mar 2020 | - | $11.15M(-200.8%) | $26.22M(+251.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | $7.46M(-102.8%) | -$11.06M(-173.0%) | $7.46M(-106.0%) |
Sep 2019 | - | $15.15M(+38.0%) | -$123.87M(-25.4%) |
Jun 2019 | - | $10.98M(-244.3%) | -$166.11M(-31.8%) |
Mar 2019 | - | -$7.61M(-94.7%) | -$243.71M(-8.3%) |
Dec 2018 | -$265.73M(>+9900.0%) | -$142.39M(+425.7%) | -$265.73M(+108.0%) |
Sep 2018 | - | -$27.09M(-59.3%) | -$127.73M(+28.7%) |
Jun 2018 | - | -$66.63M(+124.9%) | -$99.26M(+197.2%) |
Mar 2018 | - | -$29.63M(+574.0%) | -$33.40M(+1830.4%) |
Dec 2017 | -$1.73M(-157.1%) | -$4.40M(-415.8%) | -$1.73M(-142.1%) |
Sep 2017 | - | $1.39M(-282.0%) | $4.11M(+30.1%) |
Jun 2017 | - | -$765.00K(-137.5%) | $3.16M(-449.8%) |
Mar 2017 | - | $2.04M(+40.9%) | -$903.90K(-129.8%) |
Dec 2016 | $3.03M(-122.5%) | $1.45M(+228.2%) | $3.03M(-14.4%) |
Sep 2016 | - | $441.00K(-109.1%) | $3.54M(-2390.3%) |
Jun 2016 | - | -$4.83M(-180.9%) | -$154.50K(-97.9%) |
Mar 2016 | - | $5.97M(+205.3%) | -$7.50M(-44.3%) |
Dec 2015 | -$13.47M | $1.96M(-160.1%) | -$13.47M(-12.7%) |
Sep 2015 | - | -$3.25M(-73.3%) | -$15.43M(+26.7%) |
Jun 2015 | - | -$12.17M(<-9900.0%) | -$12.17M(<-9900.0%) |
Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
Jun 2014 | - | $0.00 | $0.00 |
FAQ
- What is Viking Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Viking Therapeutics?
- What is Viking Therapeutics annual CFI year-on-year change?
- What is Viking Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Viking Therapeutics?
- What is Viking Therapeutics quarterly CFI year-on-year change?
- What is Viking Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Viking Therapeutics?
- What is Viking Therapeutics TTM CFI year-on-year change?
What is Viking Therapeutics annual cash flow from investing activities?
The current annual CFI of VKTX is -$553.37M
What is the all time high annual CFI for Viking Therapeutics?
Viking Therapeutics all-time high annual cash flow from investing activities is $54.75M
What is Viking Therapeutics annual CFI year-on-year change?
Over the past year, VKTX annual cash flow from investing activities has changed by -$374.28M (-208.99%)
What is Viking Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of VKTX is $63.24M
What is the all time high quarterly CFI for Viking Therapeutics?
Viking Therapeutics all-time high quarterly cash flow from investing activities is $63.24M
What is Viking Therapeutics quarterly CFI year-on-year change?
Over the past year, VKTX quarterly cash flow from investing activities has changed by +$523.04M (+113.76%)
What is Viking Therapeutics TTM cash flow from investing activities?
The current TTM CFI of VKTX is -$30.33M
What is the all time high TTM CFI for Viking Therapeutics?
Viking Therapeutics all-time high TTM cash flow from investing activities is $74.90M
What is Viking Therapeutics TTM CFI year-on-year change?
Over the past year, VKTX TTM cash flow from investing activities has changed by +$610.75M (+95.27%)